Mounia Chaou
healthcare
Nabbir Labarotory Ltd.
Norway
Biography
Mounia Chaoui is Venture Partner at Ventech and General partner at Turenne capital in charge of Venture and Growth Capital in healthcare totaling 110 Mio EUR since 2013. Prior to this, Mounia has been a Life Science investor within Ventech (since 2001), Inserm Transfert Initiative (2012) and Atlas Venture (1998 to 1999). She has been on the board of Actogenix (sold to Intrexon), Biovex (sold to Amgen for up to 1 billion USD), Covagen (sold toJ&J), EyeGate (now EYGT), Funxional Therapeutics (sold to Boehringer Ingelheim), Prosonix (sold to Circassia), T Igenix (now EUR:TIG) and SCYNEXIS (SCYX).
Research Interest
healthcare
